DOs encouraged to participate in pharmaceutical, clinical trials.
Allen
T W
TW
D000420:Albuterol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D017298:Bisoprolol / Q000627:therapeutic use*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D017327:Clinical Trials, Phase IV as Topic; D004338:Drug Combinations; D006852:Hydrochlorothiazide / Q000627:therapeutic use*; D015274:Interdepartmental Relations; D010021:Osteopathic Medicine; D000068299:Salmeterol Xinafoate
D000959:Antihypertensive Agents; D001993:Bronchodilator Agents; D004338:Drug Combinations; C086062:bisoprolol, hydrochlorothiazide drug combination; D006852:Hydrochlorothiazide; D000068299:Salmeterol Xinafoate; D000420:Albuterol; D017298:Bisoprolol